• Quibim Announces New B...
    Post-$50M funding, Quibim appoints medtech leader Tom Tynes and top investors to its Board, accelerating FDA-cleared QP-Prostate CAD and multi-omics platform QP-Insights. 了解更多
  • Quibim Announces $50 M...
    Quibim, a leading healthtech company pioneering the use of imaging biomarkers for precision medicine, announced today the close of its $50 million Series A financing. 了解更多